Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, August 19 at 2:00 PM EDT

Register Free →

Search

Top

Back to Contracts

Pharmaceutical Manufacturer – Trazodone Tablets (100 mg)

Active

Federal

Response Deadline08/11/2026, 05:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

FORT BRAGG, NC, 28310, US

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PostedAug 5

subcontract

Response DeadlineAug 11

Submission deadline

Response Deadline

08/11/2026, 05:00:00 PM UTCin 3 days

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more

AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

ContactsNo contacts available

OfficeN/A

Organization / Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

View Agency Profile

Office AddressN/A

ContactsNo contact information available

Full Description

Show more

Manufacture and supply of Trazodone Hydrochloride 100 mg tablets in bottles of 100 units, compliant with FDA, cGMP, and military medical marking standards.

Similar Contracts

Same NAICS industry code

Custom Organic Compound Synthesis (Non-GMP)The contract involves the custom synthesis of five small-molecule compounds, each in quantities of five grams, for use in Ewing sarcoma drug development under non-GMP research conditions. The work encompasses the full scope of organic synthesis including route design, multi-step chemical reactions, and purification to yield chemically defined products suitable for preclinical evaluation. All activities are non-GMP, meaning the compounds will not be produced under regulatory quality systems required for clinical use but rather for internal research and biological testing purposes. The effort is structured as a subcontract under the National Institutes of Health, operating through the Department of Health and Human Services, with the NAICS code 325412 indicating pharmaceutical and medicine manufacturing. The solicitation was posted on August 7, 2026, and responses are due by August 24, 2026, with no set-aside designation applied. The place of performance and point of contact details are not specified, and the work is expected to be carried out by an external research or synthesis provider aligned with the NIH’s oncology drug discovery goals.

National Institutes Of Health Olao

POSTED

about 21 hours ago

DEADLINE

High-Priority Pathogen Infection PreventionThe contract seeks preventive solutions non-vaccine approaches to combat infections caused by high-priority pathogens including Pseudomonas aeruginosa and Shigella, targeting urgent public health and defense-related threats. It is issued under the Defense Health Agency within the Department of Defense and is classified as a subcontract, with the North American Industry Classification System code 325412 indicating focus on pharmaceutical preparation manufacturing. The initiative aims to advance innovative, non-pharmaceutical interventions such as antimicrobial barriers, prophylactic agents, or environmental controls that interrupt transmission or reduce pathogen load without relying on vaccines. Responses are due by October 30, 2026, and the performance location is designated as Frederick, though the full address and point of contact details are not provided. The solicitation remains open to qualified entities capable of delivering scalable, evidence-based preventive technologies aligned with military and civilian health protection needs.

Defense Health Agency

POSTED

about 21 hours ago

DEADLINE

Burn and Complex Wound Care SolutionsThe contract titled Burn and Complex Wound Care Solutions seeks advanced wound care technologies specifically designed for the treatment of burns and combat-related injuries, with eligibility contingent upon exclusion criteria outlined in the final Request for Proposals. It is issued under the NAICS code 325412, indicating a focus on pharmaceutical and medical manufacturing, and is structured as a subcontract within the Department of Defense, managed by the Defense Health Agency. The opportunity was posted on August 7, 2026, with a response deadline of October 30, 2026, and performance is expected to center in Frederick, though the exact location details are unspecified. The solicitation does not designate a specific set-aside status, and all interested parties must ensure their solutions meet the technical and clinical standards required for military medical applications while adhering to any final exclusions defined in the RPP.

Defense Health Agency

POSTED

about 21 hours ago

DEADLINE

Non-Addictive Battlefield Pain Management SolutionsThe contract seeks the development of non-opioid analgesics or alternative pain relief technologies designed for military use in austere environments, with a focus on creating effective, non-addictive solutions that can be deployed in combat or field conditions where traditional pain management options are impractical or risky. The work must address the unique challenges of battlefield medicine, including limited resources, extreme climates, and the need for rapid, reliable pain control without the potential for dependency or misuse. The technology must be robust, easily transportable, and compatible with existing military medical protocols and equipment. The contract is structured as a subcontract under the Defense Health Agency, part of the Department of Defense, and is governed by the NAICS code 325412 for pharmaceutical preparation manufacturing. Proposals must be submitted by October 30, 2026, and performance will center in Frederick, with no specific city, state, or zip provided beyond that location. There is no set-aside classification applied to this opportunity, and while no point of contact is listed, interested parties can access additional details through the provided SAM.gov link. The initiative reflects a strategic priority to reduce reliance on opioid-based treatments in military healthcare and advance innovations that enhance soldier readiness and long-term health outcomes.

Defense Health Agency

POSTED

about 21 hours ago

DEADLINE

Library of Pharmacologically Active Compounds (LOP

Solicitation # 75N98026Q00991

The National Institutes of Health, Office of the Director, Office of Acquisitions, is seeking proposals for the Library of Pharmacologically Active Compounds (LOP) under solicitation number 75N98026Q00991, issued as a competitive combined synopsis/solicitation under FAR Subpart 12.6. This procurement is conducted under streamlined procedures for commercial items, utilizing full and open competition without a separate written solicitation, and is not expected to exceed the simplified acquisition threshold. The contract will be awarded on a firm-fixed-price basis to the offeror providing the best value to the government, with proposals due by August 24, 2026. The acquisition is unrestricted and falls under the NAICS code 325412 for Pharmaceutical Preparation Manufacturing, with a small business size standard of 1,300 employees. All provisions and clauses in effect as of the Federal Acquisition Circular dated August 7, 2026, apply to this solicitation. The point of contact for inquiries is Johnstoon, Jaddua C, reachable via email at jaddua.johnston@nih.gov, and the performance location is in Bethesda, Maryland, with the award to be managed by the Department of Health and Human Services.

National Institutes Of Health Olao

POSTED

about 21 hours ago

DEADLINE

Government Contracting Compliance & GSA Schedule SupportThe contract solicits the supply of biotechnology reagents through existing GSA Schedule or GWAC vehicles, requiring full compliance with the Federal Acquisition Regulation for pricing and delivery terms. All offerings must leverage pre-negotiated, FAR-compliant contractual mechanisms to ensure transparency, affordability, and efficiency in procurement by the National Institutes of Health, specifically the National Institute on Drug Abuse under the Department of Health and Human Services. The NAICS code 325412 confirms the primary focus on pharmaceutical and biological product manufacturing, indicating the need for high-purity, research-grade reagents suitable for scientific and clinical applications. Responses must be submitted by August 13, 2026, and the contract is structured as a subcontract, implying the awardee will fulfill obligations under a prime contract holder rather than directly with the government. Performance is expected to align with federal supply chain standards, though no specific place of performance or set-aside criteria are provided. Compliance with GSA Schedule or GWAC terms is mandatory, ensuring that pricing remains consistent with established federal rates and that delivery timelines meet agency operational needs. The solicitation underscores the importance of proven regulatory adherence and reliable supply chain execution to support critical biomedical research activities.

National Institutes Of Health Nida

POSTED

DEADLINE

Specialty Biotech Reagent Manufacturing (dCODE Dextramer®)The contract involves the manufacture of specialized immunology reagents based on dextramer technology, specifically customizable HLA-peptide complexes equipped with fluorescent barcoding, intended for use in research and clinical applications. These reagents are designed to enable precise detection and analysis of antigen-specific T cells, supporting advancements in immunological studies and potential therapeutic development. The production must meet stringent quality and consistency standards to ensure reliability across diverse experimental and diagnostic settings, with an emphasis on scalability and customization to accommodate varying peptide and HLA combinations. This is a subcontract under the National Institutes of Health, specifically the National Institute on Drug Abuse, part of the Department of Health and Human Services, with the NAICS code 325412 indicating biological product manufacturing. The opportunity was posted on August 6, 2026, and responses are due by August 13, 2026, with no set-aside classification specified. The place of performance and other location details are not provided, indicating flexibility in where the manufacturing may occur, though all work must comply with the technical and regulatory requirements for clinical-grade reagents. The focus is squarely on advanced biotech manufacturing capabilities, emphasizing precision, reproducibility, and compliance with industry best practices for immune monitoring tools.

National Institutes Of Health Nida

POSTED

DEADLINE

Supplier of Universal 5' Gene Expression Kits

National Institutes Of Health Nida

POSTED

DEADLINE

Supplier of Feature Barcode Kits for Single-Cell Analysis

National Institutes Of Health Nida

POSTED

DEADLINE

Supplier of Chromium GEM-X Single Cell 5' Chip Kits

National Institutes Of Health Nida

POSTED

DEADLINE

Supplier of Single-Cell Library Construction Kits

National Institutes Of Health Nida

POSTED

DEADLINE

Virus-Vectored Oral Rabies Vaccine Bait – Fishmeal Polymer FormulationThe contract pertains to the supply of fishmeal polymer-based vaccine baits with part number 128425, specifically formulated as a virus-vectored oral rabies vaccine intended for targeted wildlife species. These baits are designed to deliver rabies immunization in a palatable, durable form that supports effective distribution in野外 environments, leveraging a fishmeal polymer matrix to ensure stability and attraction for target animals. The work under this subcontract is tied to efforts led by the USDA’s APHIS-Wildlife Services division to manage and reduce the spread of rabies among wildlife populations through strategic oral vaccination campaigns. The solicitation was posted on August 6, 2026, with submissions due by September 7, 2026, at 9:00 PM. The North American Industry Classification System code 325412 indicates the work falls under pharmaceutical and biological product manufacturing, underscoring the scientific and regulatory rigor expected in production. Performance is required to occur in Concord, New Hampshire, with a ZIP code of 03301, though no specific office address or point of contact is provided. The nature of the contract as a subcontract suggests it supports a broader federal wildlife health initiative, likely underpinning national or regional rabies control programs managed by the Department of Agriculture.

POSTED

DEADLINE

in about 1 month

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

Export-Controlled Items Compliance (ITAR/EAR)

Administrative Management and General Management Consulting Services

POSTED

DEADLINE

Cybersecurity Compliance for Covered Defense Information (CDI)

Computer Systems Design Services

POSTED

DEADLINE

Hazardous Materials Compliance & Safety Data Management

Other Scientific and Technical Consulting Services

POSTED

DEADLINE

Pharmaceutical Supply – Albuterol Sulfate Inhalation Aerosol

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

Domestic and International Pharmaceutical LogisticsThis contract facilitates the domestic and international transportation of pharmaceuticals under FOB Destination terms to Joint Region Marianas, GU, with mandatory climate-controlled shipping options to ensure the integrity of temperature-sensitive medications. Delivery confirmation is required upon completion, ensuring accountability and traceability throughout the logistics chain. The North American Industry Classification System code 484220 indicates the focus on general freight trucking, specifically for specialized cargo such as pharmaceuticals. The solicitation is issued by the Department of Defense under the Medical Supply Chain Pharm FSA, with performance occurring at a military postal address in APO, ZIP 96543-4010. The opportunity is structured as a subcontract with a response deadline of August 11, 2026, and was posted on August 5, 2026, indicating a narrow window for interested parties to submit proposals. Specific contact details and set-aside information are not provided, and bidders must rely on the official DIBBS platform link for full solicitation documentation.

Specialized Freight (except Used Goods) Trucking, Local

POSTED

DEADLINE

Medical Item Labeling and Marking (MMS No. 1 Compliance)The contract requires precise labeling of medical items in full compliance with Medical Marking Standard No. 1A, ensuring complete traceability through the inclusion of NSN, CAGE code, lot number, and expiration date on each label. This work is critical for maintaining supply chain integrity across Department of Defense medical logistics and must be executed with strict adherence to the published marking standards. The subcontract is issued under NAICS code 323111 and is intended for performance at APO, zip code 96543-4010, with a response deadline of August 11, 2026, and was posted on August 5, 2026. The contracting activity is managed under the Medical Supply Chain Pharm FSA, operating within the Department of Defense framework, and all submissions must be directed through the official DIBBS RFQ portal linked in the solicitation.

Commercial Printing (except Screen and Books)

POSTED

DEADLINE

Hazardous Materials Labeling and ComplianceThe contract requires strict adherence to OSHA’s Hazard Communication Standard and DFARS requirements for pharmaceutical labeling, ensuring all materials are properly identified, classified, and labeled to communicate chemical hazards accurately. A critical component is the mandatory pre-award submission of labeling for review and approval, which must be completed before any contract award is finalized. Compliance must be maintained throughout the lifecycle of the pharmaceutical products being labeled, with all documentation and procedures aligned to federal regulatory frameworks governing hazardous materials in defense-related supply chains. The subcontract is tied to the Department of Defense’s Medical Supply Chain Pharm FSA and specifies APO 96543-4010 as the place of performance, indicating logistics and labeling operations are expected to support military medical logistics globally. The NAICS code 541690 classifies the work under other scientific and technical consulting services, reflecting the specialized nature of regulatory compliance and labeling expertise required. The response deadline is August 11, 2026, with the solicitation posted on August 5, 2026, leaving a limited window for qualified vendors to submit proposals through the DIBBS system. All submissions must demonstrate proven capability in navigating both occupational safety and defense acquisition regulations.

Other Scientific and Technical Consulting Services

POSTED

DEADLINE

Medical Packaging and Preservation ServicesThe contract entails the commercial and export-grade packaging of pharmaceutical units in sealed, protective containers that adhere to MIL-STD-2073-1E standards and military preservation requirements, ensuring long-term stability and integrity under harsh logistical conditions. The work requires strict compliance with defense-grade packaging protocols to safeguard sensitive medical products throughout storage and transit, particularly for deployment in austere or remote environments. Packaging must be designed to withstand extended periods, extreme temperatures, humidity, and physical stress while maintaining sterility and labeling accuracy. This subcontract is issued by the Department of Defense through the Medical Supply Chain Pharm FSA, with performance to be conducted at APO, ZIP 96543-4010. The solicitation was posted on August 5, 2026, and responses are due by August 11, 2026. The NAICS code 326199 indicates it falls under other plastics product manufacturing, reflecting the specialized nature of the protective packaging materials involved. The scope is focused on end-to-end packaging services tailored to military medical supply chains, with no set-aside provisions indicated, meaning any qualified contractor may bid, and the expectation is on technical precision, certification compliance, and adherence to military preservation norms.

All Other Plastics Product Manufacturing

POSTED

DEADLINE

Pharmaceutical Manufacturing and Supply – Oral ContraceptivesThe contract calls for the manufacture and supply of FDA-approved oral contraceptive tablets containing Norethindrone and Ethinyl Estradiol, USP, meeting a minimum 36-month shelf life and adhering to current good manufacturing practices. The product must also comply with military preservation standards to ensure stability and integrity under field conditions. Production and packaging are required to align with cGMP regulations and the specific demands of the Department of Defense supply chain, with the intended delivery point being APO, ZIP 96543-4010. This is a subcontract opportunity issued under NAICS code 325412, targeting manufacturers capable of consistent, high-volume production for federal procurement. Responses must be submitted by August 11, 2026, following the solicitation issued by the Medical Supply Chain Pharm FSA, which operates under the Department of Defense. All parties must be prepared to meet stringent quality, documentation, and logistical requirements to fulfill military-grade distribution needs.

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE

Packaging, Preservation & LogisticsThe contract requires the provision of military-compliant packaging, preservation, and logistics services for medical supplies, ensuring all items meet stringent shelf-life and transportation standards as dictated by defense protocols. All components must be prepared and handled to maintain integrity during transit and storage, with strict adherence to military specifications for environmental resilience, tamper-evident sealing, and labeling requirements. The work must support the operational readiness of military medical units by guaranteeing that supplies arrive in fully functional, sterile, and date-valid condition regardless of deployment location or environmental conditions. Performance is centered at Fort Drum, New York, with the delivery schedule and quality controls tightly linked to the Department of Defense’s Medical Supply Chain Pharm FSA requirements. Subcontractors must demonstrate proven capability in handling sensitive medical inventory under military-grade logistics frameworks, including compliance with NAICS code 493190 for other warehousing and storage activities. Responses are due by August 11, 2026, and the opportunity is structured as a subcontract under a broader defense procurement effort. All proposals must align with the DLA’s DIBBS system, and successful bidders will be expected to maintain continuous compliance with defense logistics protocols throughout the contract term.

Other Warehousing and Storage

POSTED

DEADLINE

Regulatory Compliance & Labeling ServicesThe contract seeks a subcontractor to prepare and submit hazard communication labels, safety data sheets, and related regulatory documentation in accordance with OSHA, FDA, and DLA standards, ensuring full compliance with federal safety and labeling requirements for medical supply chain operations. The work is tied to the Department of Defense’s Medical Supply Chain Pharm FSA and must be performed at Fort Drum, New York, with an zip code of 13602-5004, indicating the physical location where deliverables are to be managed or coordinated. The solicitation is classified under NAICS code 541690, which covers other scientific and technical consulting services, emphasizing the technical and compliance-oriented nature of the tasks. All proposals must be submitted by August 11, 2026, with the solicitation posted on August 5, 2026, providing a six-day window for responses. The contract is structured as a subcontract, meaning the awarded entity will work under a prime contractor or larger program rather than directly with the government agency. There is no set-aside designation specified, so all eligible businesses may compete regardless of size or ownership status. The official solicitation is accessible via the DIBBS platform using the provided link, and while no point of contact is listed, potential bidders must ensure all submitted materials meet the precise regulatory frameworks governing hazardous material documentation for military and medical use.

Other Scientific and Technical Consulting Services

POSTED

DEADLINE

Supply of Fluorescein Sodium Ophthalmic StripsThe contract solicits the manufacture and delivery of Fluorescein Sodium Ophthalmic Strips that comply with FDA regulations and are packaged in sealed unit containers to meet strict military standards for packaging, labeling, and shelf-life. These strips are intended for ophthalmic use and must adhere to the Department of Defense’s specifications for quality, sterility, and longevity under operational conditions. The product will be delivered to Fort Drum, New York, with all packaging and documentation aligned to military logistics and traceability requirements. This is a subcontract issued under NAICS code 325412, which pertains to pharmaceutical preparation manufacturing, and was posted on August 5, 2026, with responses due by August 11, 2026. The contracting activity is managed by the Medical Supply Chain Pharm FSA under the Department of Defense, indicating this is part of a broader defense medical supply initiative. All bidders must ensure full compliance with federal pharmaceutical and defense packaging regulations, and deliveries must be timed to meet operational readiness schedules at the specified location.

Pharmaceutical Preparation Manufacturing

POSTED

DEADLINE